Neurocrine Clinical Site

Hialeah, Florida 33018

2 studies enrolling now · 10 studies all time

What they study most

Bipolar Disorder, Major Depressive Disorder, Schizoaffective Disorder, Schizophrenia, Tardive Dyskinesia, Tardive Dyskinesia (TD), Tourette Syndrome

Studies at this site

• Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia — Recruiting now
• A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor — Recruiting now
• Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia — Completed
• Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome — Stopped early
• Rollover Study for Continuing NBI-98854 Administration in Pediatric Subjects With Tourette Syndrome — Stopped early
• Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome — Completed
• Safety, Tolerability, and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome — Completed
• Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia — Completed
• The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine — Completed
• Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents — Status unconfirmed